…on your website? https://www.aimatmelanoma.org/melanoma-learning-center/side-effect-management-guides/ https://themelanomanurse.org/side-effect-search-section/ https://www.aimatmelanoma.org/wp-content/uploads/AIM-YERVOY-MULTIPAGE.pdf https://www.aimatmelanoma.org/wp-content/uploads/AIM-OPDIVO-YERVOY-MULTIPAGE-1.pdf https://www.youtube.com/playlist?list=PLOnM_erAQqICO-gEouc_MRXGzcFBVC0Il   References: Frey C and Etminan M. Adverse Events of PD-1, PD-L1,…

Sixth Article in a Series Are you familiar with The Supporters Guild, AIM’s Monthly Giving Program? It empowers you to…

…melanoma cohort of the IGNYTE clinical trial. “Today is an important milestone for Replimune and for the melanoma community as…

…BRAF mutant melanoma. This study is called “Dream Seq,” and readers might recall that the initial results were revealed at…

…personalized vaccine continued to cut the risk of death or recurrence of the most deadly skin cancer five years after…

…Stovall Award in Cancer Survivorship from ASCO, and the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School.…

…cousin, who is a physician, Angela secured a dermatology appointment in Louisiana. “The dermatologist looked at it, promptly biopsied it,…

…treatment of advanced melanoma in patients who progress on an anti-PD-1 containing regimen. The PDUFA date set by the FDA…

…10 million readers. Find the campaign in LA Times or read it online: https://www.futureofpersonalhealth.com/campaign/skin-health/ Read the articles AIM contributed to…

In this episode, Dr. Ray Liu and Melissa Wilson, PA-C, MPAS, Melanoma Lead at UPMC Hillman Cancer Center, and AIM’s…